ISRCTN53817258已完成未知
Second-line Anti-Retroviral therapy in Africa: a randomised trial to evaluate the feasibility of maintenance monotherapy with ritonavir-boosted lopinavir (Aluvia® tablets) following initiation with 24 weeks of combination therapy in second-line anti-retroviral therapy in Africa
Medical Research Council Clinical Trials Unit (UK)0 个研究点目标入组 240 人开始时间: 2007年5月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Enrolled in the DART trial (ISRCTN13968779 at http://www.controlled-trials.com/ISRCTN13968779)
- •2. Failed first-line antiretroviral therapy (clinically/immunologically) and having completed 24 weeks of second-line combination antiretroviral therapy including ritonavir-boosted lopinavir (as either Aluvia® heat-stable tablets or Kaletra® capsules)
- •3. Documented informed consent
- •4. Life expectancy of at least 3 months
排除标准
- •Pregnant or breast-feeding
研究者
相似试验
已完成
不适用
Development of AntiRetroviral Therapy in Africa - a randomised trial of monitoring practice and structured treatment interruptions in the management of antiretroviral therapy in adults with HIV infection in AfricaHuman Immunodeficiency Virus (HIV), Acquired Immunodeficiency Syndrome (AIDS)Infections and InfestationsHuman immunodeficiency virus (HIV)ISRCTN13968779Medical Research Council (MRC) (UK)3,300
已完成
不适用
Compliance to Anti-Retroviral Therapy among African-Brazilians in Southern BrazilHIV / AIDSJPRN-UMIN000001092niversity of Caxias do Sul, Brazil100
Unknown
3 期
Nucleosides And Darunavir/Dolutegravir In AfricaHuman Immunodeficiency VirusNCT03988452Makerere University465
已完成
2 期
Tenofovir-lamivudine-dolutegravir Combination as Second-line ART: a Randomised Controlled TrialHIV InfectionsNCT03991013University of Cape Town192
进行中（未招募）
1 期
Antiretroviral treatment with maraviroc plus ritonavir-boosted darunavir for early salvage therapyAdult patients with HIV-1 infection that present virologic failure to first-line antiretroviral treatment.MedDRA version: 14.1Level: PTClassification code 10020161Term: HIV infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2012-003501-10-ESVall d'Hebron Institut de Recerca (VHIR)90